Assesses the genetic risk of abnormal drug metabolism for CYP2C19 substrates. May aid in drug selection and dose planning for drugs metabolized by CYP2C19
Interpretive report provided
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
5 - 10 days
Collect specimen in a Lev (EDTA), Pink or ACD Soln A or B tube. Send whole blood to Specimen Processing refrigerated
Test performed by ARUP Laboratories